European Commission to receive fewer Pfizer-BioNTech vaccine doses under amended contract

The European Commission has made a few changes to its vaccine contract with Pfizer and BioNTech, reducing the dose volume while extending the delivery timeline to cope with “evolving public health needs.” The Commission previously struck a contract in May 2021 for 900 million doses, with the option to purchase…

Click here to view original post

Advertise With Biotech Networks

Be the first to comment

Leave a Reply

Your email address will not be published.